Acrivon Therapeutics
(NASDAQ) ACRV
Acrivon Therapeutics Financials at a Glance
Market Cap
$51.53M
Revenue (TTM)
$0.00
Net Income (TTM)
$77.91M
EPS (TTM)
$-2.02
P/E Ratio
-0.66
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$1.34
Volume
594,665
Open
$1.38
Price
$1.34
Volume
594,665
Open
$1.38
Previous Close
$1.33
Daily Range
$1.33 - $1.41
52-Week Range
$1.05 - $3.56
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$1.34
Volume
594,665
Open
$1.38
Previous Close
$1.33
Daily Range
$1.33 - $1.41
52-Week Range
$1.05 - $3.56
ACRV News
ACRV: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Acrivon Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
76
CEO
Peter Blume-Jensen, MD, PhD
Website
acrivon.comHeadquarters
Watertown, MA 02472, US
ACRV Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-54%
Return on Capital
-74%
Return on Assets
-60%
Earnings Yield
-1.52%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$51.53M
Shares Outstanding
38.74M
Volume
594.66K
Short Interest
0.00%
Avg. Volume
1.72M
Financials (TTM)
Gross Profit
$1.36M
Operating Income
$84.11M
EBITDA
$82.76M
Operating Cash Flow
$63.66M
Capital Expenditure
$1.67M
Free Cash Flow
$65.33M
Cash & ST Invst.
$118.58M
Total Debt
$2.71M
Acrivon Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$911.00K
+400.7%
Gross Margin
0.00%
N/A
Market Cap
$51.53M
N/A
Market Cap/Employee
$687.07K
N/A
Employees
75
N/A
Net Income
$18.98M
+16.8%
EBITDA
$26.11M
-15.9%
Quarterly Fundamentals
Net Cash
$115.87M
-34.1%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$3.07M
+18.8%
Short Term Debt
$1.17M
+10.9%
Return on Assets
-60.06%
N/A
Return on Invested Capital
-73.75%
N/A
Free Cash Flow
$15.46M
+15.0%
Operating Cash Flow
$15.24M
+12.2%